Deep-Ultraviolet Resonance Raman (DUVRR) Spectroscopy of Therapeutic Monoclonal Antibodies Subjected to Thermal Stress
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
The structural assessment of Rituximab, an IgG1 mAb, was investigated with deep-ultraviolet resonance Raman (DUVRR) spectroscopy. DUVRR spectroscopy was used to monitor the changes to the secondary structure of Rituximab under thermal stress. DUVRR spectra showed obvious changes from 22 to 72 °C. Specifically, changes in the amide I vibrational mode were assigned to an increase in unordered structure (random coil). Structural changes in samples heated to 72 °C were related to loss in drug potency via a complement dependent cytotoxicity (CDC) bioassay. The DUVRR spectroscopic method shows promise as a tool for the quality assessment of mAb drug products and would represent an improvement over current methodology in terms of analysis time and sample preparation. To determine the scope of the method, protein pharmaceuticals of different molecular weights (ranging from 4 to 143 kDa) and secondary structure (β-sheet, α-helix and unordered structure) were analyzed. The model illustrated the method's sensitivity for the analysis of protein drug products of different secondary structure. Results show promise for DUVRR spectroscopy as a rapid screening tool of a variety of formulated protein pharmaceuticals.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Two recent papers from the FDA’s CDER Division of Pharmaceutical Analysis, Office of Testing and Research demonstrate deep-UV resonance Raman for understanding mAb structure under normal and stressed conditions [114, 115].”
From The role of Raman spectroscopy in biopharmaceuticals from development to manufacturing (2022) · cites this paper as [114]
Citations
Cites
Human serum albumin: From bench to bedside
Fanali, G., di Masi, A., Trezza, V., Marino, M., Fasano, M., & Ascenzi, P. (2012) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2011.12.002 · Cited by 1,931
Effects of protein aggregates: An immunologic perspective
Rosenberg, A. S. (2006) · The AAPS Journal · doi:10.1208/aapsj080359 · Cited by 1,355
Bioequivalence and the immunogenicity of biopharmaceuticals
Schellekens, H. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd818 · Cited by 534
Aggregates in monoclonal antibody manufacturing processes
Vázquez‐Rey, M., & Lang, D. A. (2011) · Biotechnology and Bioengineering · doi:10.1002/bit.23155 · Cited by 479
Chi, Z., Chen, X. G., Holtz, J. S. W., & Asher, S. A. (1998) · Biochemistry · doi:10.1021/bi971160z · Cited by 301
UV Resonance Raman Investigations of Peptide and Protein Structure and Dynamics
Oladepo, S. A., Xiong, K., Hong, Z., Asher, S. A., Handen, J., & Lednev, I. K. (2012) · Chemical Reviews · doi:10.1021/cr200198a · Cited by 214
Joshi, V. S., Shivach, T., Yadav, N., & Rathore, A. S. (2014) · Analytical Chemistry · doi:10.1021/ac503140j · Cited by 153
Protein secondary structure from deep‐UV resonance Raman spectroscopy
Huang, C., Balakrishnan, G., & Spiro, T. G. (2006) · Journal of Raman Spectroscopy · doi:10.1002/jrs.1440 · Cited by 139
Telikepalli, S. N., Kumru, O. S., Kalonia, C., Esfandiary, R., Joshi, S. B., Middaugh, C. R., & Volkin, D. B. (2014) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23839 · Cited by 138
Structural Basis for Recognition of CD20 by Therapeutic Antibody Rituximab
Du, J., Wang, H., Zhong, C., Peng, B., Zhang, M., Li, B., Huo, S., Guo, Y., & Ding, J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701654200 · Cited by 134
Research works printed but not linked: 1
- Aggarwal S. R., 2014, Nature, 201, 33
Cited by
Protein aggregation – Mechanisms, detection, and control
Wang, W., & Roberts, C. J. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.08.043 · Cited by 299
The role of Raman spectroscopy in biopharmaceuticals from development to manufacturing
Esmonde-White, K. A., Cuellar, M., & Lewis, I. R. (2022) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-021-03727-4 · Cited by 152
“Two recent papers from the FDA’s CDER Division of Pharmaceutical Analysis, Office of Testing and Research demonstrate deep-UV resonance Raman for understanding mAb structure under normal and stressed conditions [114, 115].”
BackgroundEngaging with Raman Spectroscopy to Investigate Antibody Aggregation
Ettah, I., & Ashton, L. (2018) · Antibodies · doi:10.3390/antib7030024 · Cited by 65
“In particular, a peak shift, along with a broadening of the peak, was observed from ~1670 to 1660 cm−1 with heating indicating an increase in less-ordered structure [73].”
BackgroundMethodChen, K., Long, D. S., Lute, S. C., Levy, M. J., Brorson, K., & Keire, D. A. (2016) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2016.06.007 · Cited by 51
“, deep UV-resonance Raman [8], circular dichroism (CD) and NMR [9-14], hydrodynamic techniques, e.”
BackgroundSelf-citationWei, B., Woon, N., Dai, L., Fish, R., Tai, M., Handagama, W., Yin, A., Jia, S., Maier, A. J., McDaniel, D., et al. (2021) · mAbs · doi:10.1080/19420862.2021.2007564 · Cited by 39
“27 McAvan et al. demonstrated the capability of using Raman spectroscopy to differentiate between force-degraded monoclonal antibody with different levels of PTMs. 28 While Raman spectroscopy has been implemented as a quality control (QC) method in small-molecule drug development and manufacturing,…”
Metadata
- Authors
- Bueno, J., Long, D., Kauffman, J. F., & Arzhantsev, S.
- Affiliations
- United States Food and Drug Administration (US)
- Division of Pharmaceutical Analysis, Office of Testing and Research, Center for Drug Evaluation and Research, Food and Drug Administration, 645 S. Newstead Avenue, St Louis, Missouri 63110, United States
- Corresponding author
- Bueno, Justin
- ORCID
- Long, Dianna
- Venue
- Analytical Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2015-07-14
- Volume
- 87
- Issue
- 15
- Pages
- 7880-7886
- ISSN
- 0003-2700 (ISSN-L)
- 1520-6882
- OpenAlex
- W2415935448
- Cited by
- 14
- References
- 23
- Citations by year
- 2026: 1 · 2023: 2 · 2022: 1 · 2021: 3 · 2019: 2 · 2018: 3 · 2016: 2
- FWCI
- 1.01
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Analytical Chemistry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Food and Drug Administration
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biophysics › Spectroscopy Techniques in Biomedical and Chemical Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein purification and stability
- Life Sciences › Immunology and Microbiology › Immunology › Biosimilars and Bioanalytical Methods
- Keywords
- rituximab, monoclonal antibodies, thermal stress (biology), protein secondary structure, random coil, complement-dependent cytotoxicity, drug potency, IgG1 antibodies
- MeSH terms
- Rituximab, Hot Temperature, Spectrophotometry, Ultraviolet, Spectrum Analysis, Raman, Time Factors, Protein Structure, Secondary
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.